Success Stories: NIW Approval Received for an Indian Researcher III Working in the Field of Cancer Biology with Our Support
Client’s Testimonial:
“I would like to thank you and your office for accepting my case and helping me throughout the process.”
On August 16th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher III in the Field of Cancer Biology (Approval Notice).
General Field: Cancer Biology
Position at the Time of Case Filing: Researcher III
Country of Origin: India
State of Residence at the Time of Filing: Minnesota
Approval Notice Date: August 16th, 2021
Processing Time: 9 months, 24 days
Case Summary:
The application process for various immigration petitions at USCIS can be a tiring process without the aid of a legal firm. It is here that we come in with the accumulated expertise of thousands of case approvals. So, as soon as a client contacts us to hire our help in the adjudication process, we try our best to ascertain the potential of their claims before countersigning the retainer agreement.
In August 2021, we were approached by an Indian researcher III working in the field of cancer biology, to help him file an NIW (National Interest Waiver) application on his behalf. In order to ensure the success of his case, we went ahead and customized his petition to play to his strengths. This made us look at his professional and academic career thus far. In digging at these angles, we came up with information about his publications, citations as well as grants or funding he had received to date. We also made sure that the value of his ongoing work for the U.S. was not lost on the adjudicating judge. For this, we included a detailed overview of his CV and transcripts.
Some of the information we found helpful is as follows:
- His proposed endeavor is to continue his research on identifying the changes in the gene expression profile and molecular pathways that cause cancer in order to develop prognostic biomarkers for predicting therapy effectiveness. His work is relevant to the development of more effective alternative therapies for the long-term treatment of cancer. His research addresses this imperative by facilitating the development of effective alternative treatments for cancer, thus his work holds significant financial and public health value for the United States.
- His work has resulted in 9 peer-reviewed journal articles (1 of them first-authored), as well as 11 published poster abstracts.
- His publications have also been cited a total of 42 times according to Google Scholar.
- On the other hand, his research has been supported by funding from a leading agency, demonstrating the recognized value and importance of his work. This funding includes grants from the Department of Defense Ovarian Cancer Research Program.
“As a whole, [his] vast wealth of experience in the field has afforded him with a comprehensive skill set and level of ingenuity that few researchers possess and has laid the foundation for his various scientific breakthroughs. In light of this outstanding background and his research achievements, [client] is a researcher of the highest rank, and his continued presence is of tremendous benefit to both the field of molecular biology and the United States.”
We are grateful to him for showing trust in our firm to represent him in his NIW case. We wish him the very best in life.